Complement decay-accelerating factor, also known as CD55 or DAF, is a protein that, in humans, is encoded by the CD55 gene. [5] DAF regulates the complement system on the cell surface. It …

Mar 28, 2025 · CD55 (CD55 Molecule (Cromer Blood Group)) is a Protein Coding gene. Diseases associated with CD55 include Complement Hyperactivation, Angiopathic Thrombosis, And …

Decay-accelerating factor (DAF or CD55) is a known inhibitor of the complement system and has recently attracted substantial attention due to its role in various diseases, such as cancer, …

Decay accelerating factor (CD55, DAF) is a membrane-bound protein which protects host cells by inhibiting over activation of C4bC2a of the classical pathway and C3 convertase of the …

Feb 21, 2005 · Decay-accelerating factor ([DAF] CD55) is a glycosylphosphatidylinositol-anchored membrane inhibitor of complement with broad clinical relevance. Here, we establish an …

The major isoform of DAF, or CD55, is a 70-kD plasma membrane protein that is widely distributed on all blood cells and on endothelial and epithelial tissues. The physiologic role of …

Studies of decay-accelerating factor (DAF) function and structure are reviewed. DAF was first recognized as a species restricting factor operating at the level of C3/C5 activation. Cloning of …

Aug 1, 2006 · The decay-accelerating factor (DAF, CD55) physiologically serves as an inhibitor of the complement system. Moreover, DAF is broadly expressed in malignant tumors.

May 15, 1999 · NH 2-terminal protein sequencing of the 66/72 kDa bands showed identity with CD55 or DAF. CD55 was originally purified by Nicholson-Weller from human erythrocytes (22) …

Decay-accelerating-factor (DAF, CD55), a phosphatidyl-inositol anchored glycoprotein, is a member of the cell membrane bound complement regulatory proteins that inhibit autologous …